COVID, glyhealth, glycans, immunofrailty, immunology, immune system

GlyHealth COVID

£0.00

GlyHealth-COVID is being developed to identify immunofrail individuals likely to suffer serious inflammatory episodes if they were to be infected with SARS-Cov-2 virus.

The first phase of this program was being funded as part of the UK Research and Innovation (UKRI) initiative for research addressing COVID-19 with blood samples from patients across the UK, Europe and the US. See more details here.  Our preliminary results indicate that there are blood glycomics patterns of individuals that seem to correlate with health outcomes after SARS-Cov-2 infection. 

Read more

Out of stock

Related products

  • Immunofrailty Test

    Rated 0 out of 5
    £250.00 Add to cart

    Glycan-based test that measures the fitness of your immune system and helps to learn about the nature of your inflammation from a small amount of blood.

  • GlyHealth-IBD

    Rated 0 out of 5
    £0.00 Add to cart

    GlyHealth-IBD is the most advanced of our disease-specific GlyHealth variants. It is a prognostic and predictive biomarker of inflammatory bowel disease (IBD).